Azam Nayebaghayee; Seyed Ali Aleyasin; Hassan Heidari; Hosein Davodi
Abstract
The present study aimed at investigating the effectiveness of metacognitive therapy on dysfunctional beliefs, inflated sense of responsibility, and intolerance of uncertainty in patients with obsessive compulsive-disorder (OCD). The design used in the present study is semi-experimental, pretest-posttest ...
Read More
The present study aimed at investigating the effectiveness of metacognitive therapy on dysfunctional beliefs, inflated sense of responsibility, and intolerance of uncertainty in patients with obsessive compulsive-disorder (OCD). The design used in the present study is semi-experimental, pretest-posttest with control group and a tree-month follow-up stage. The statistical population consisted of all patients with OCD in Mahallat, a city located in Markazi province, Iran in 2018. The participants first screened by using inclusion and exclusion criteria. Then sixteen patients with OCD selected as the sample of the study through available sampling method and assigned randomly into two groups: one experimental group and one control group (eight patients in each group). Each participant in the experimental group received 12 treatment sessions according to Well's metacognitive therapy method for OCD. The participants were measured both before and after interventions as well as three months later in the follow-up phase by the Yale-Brown Obsessive-Compulsive Scale (Yale-BOCS; Goodman, 1989), the Obsessive Beliefs Questionnaire (OBQ-44; OCCWG, 2005), the Salkovskis Responsibility Attitude Scale (RAS; Salkovskis, 2000) and the Intolerance of Uncertainty Scale (IUS; Feriston, 1994). Data analyzed by multivariate co-variance analysis. The results indicated that metacognitive therapy had a significant effect on reducing dysfunctional beliefs, the inflated sense of responsibility and the variable intolerance of uncertainty (p˂0.050), and its effect remained three months after treatment (p˂0.050). The findings of the study support the effect of metacognitive therapy in improving the dysfunctional beliefs, inflated sense of responsibility and uncertainty of intolerance in patients with OCD.
Inchenaz Asaszadeh; Majid Mahmoudalilou
Abstract
Breast cancer, being the most common type of cancer among women, causes anxiety, depression, hopelessness, and anger. Metacognitive therapy is a new approach that puts emphasis on reducing useless cognitive processes instead of the cognitive content of thoughts and also on facilitating metacognitive ...
Read More
Breast cancer, being the most common type of cancer among women, causes anxiety, depression, hopelessness, and anger. Metacognitive therapy is a new approach that puts emphasis on reducing useless cognitive processes instead of the cognitive content of thoughts and also on facilitating metacognitive processing. Based on the single-case experimental research, the study intended to examine the effectiveness of metacognitive therapy on depression and hope-to-life in women with breast cancer. The study drew on a multiple-baseline design in which three individuals from Women’s Breast Cancer Association in Tabriz received the intended 8-session treatment. The instruments used for data gathering were Beck Depression Inventory (BDI –II) and Life Expectancy scale. Results show that the highest percentage of improvement was related to physical and emotional symptoms of depression and also to the life expectancy, which was 75% and the lowest percentage was 50%. Concerning the cognitive symptoms of depression, the highest percentage of improvement was 100% and the lowest was 50%. Findings also suggest that the effectiveness of the metacognitive therapy for the three participants was consistent at the follow-up testing. Therefore, it is suggested that metacognitive therapy be used for reducing depression and increasing life expectancy in women with breast cancer.
seyedeh Ayda mousavi Moghadam; Mansour Bairami; Abbas bakhshipour; Hasan HamidPour
Abstract
This study evaluated the efficacy of metacognitive therapy (MCT) on reducing the pathological symptoms and trait anxiety of patients suffering from generalized anxiety disorder. The current study employed a multiple baseline single case study design. Patients with GAD (3 women and 2 men) meeting DSM-IV ...
Read More
This study evaluated the efficacy of metacognitive therapy (MCT) on reducing the pathological symptoms and trait anxiety of patients suffering from generalized anxiety disorder. The current study employed a multiple baseline single case study design. Patients with GAD (3 women and 2 men) meeting DSM-IV criteria for GAD were selected using purposeful sampling method and participated in the therapeutic intervention after obtaining treatment requirements. The treatment consisted of 8–12 weekly sessions. Assessments were conducted at pre-treatment, post-treatment, 6, and 12-month follow-up on several clinical measures: Generalized Anxiety Disorder Questionnaire (GAD-Q-IV), Beck anxiety inventory (BAI) and Trait-Anxiety Subscale of the State-Trait-anxiety inventory (STAI-T). Data were analyzed using the index of improvement percentage and reliable change index (RCI). The results showed that MCT was significantly effective in reducing treatment's target. It can be concluded that metacognitive therapy has appropriate efficacy in the treatment of men and women with generalized anxiety disorder.
